-
1
-
-
0025185669
-
Radical prostatectomy for clinical T1-2N0M0 prostatic adenocarcinoma: Long term results
-
Paulson DF, Moul JW, and Walther PJ: Radical prostatectomy for clinical T1-2N0M0 prostatic adenocarcinoma: long term results. J Urol 144: 1180-1184, 1990.
-
(1990)
J Urol
, vol.144
, pp. 1180-1184
-
-
Paulson, D.F.1
Moul, J.W.2
Walther, P.J.3
-
2
-
-
0029059020
-
Randomized prospective study comparing radical prostatectomy alone versus radical prostatectomy preceded by androgen blockade in clinical stage B2 (T2bNxM0) prostate cancer: The Lupron Depot Neoadjuvant Prostate Cancer Study Group
-
Soloway MS, Sharifi R, Wajsman Z, McLeod D, Wood DP, and Puras-Baez A: Randomized prospective study comparing radical prostatectomy alone versus radical prostatectomy preceded by androgen blockade in clinical stage B2 (T2bNxM0) prostate cancer: the Lupron Depot Neoadjuvant Prostate Cancer Study Group. J Urol 154: 424-428, 1995.
-
(1995)
J Urol
, vol.154
, pp. 424-428
-
-
Soloway, M.S.1
Sharifi, R.2
Wajsman, Z.3
McLeod, D.4
Wood, D.P.5
Puras-Baez, A.6
-
3
-
-
0000177452
-
Randomized prospective study: Radical prostatectomy alone vs. radical prostatectomy preceded by androgen block-age in cT2b prostate cancer
-
abstract 976
-
Soloway MS, Sharifi R, Wajsman Z, McLeod D, Wood D, Puras-Baez A, and the Lupron Depot Neoadjuvant Study Group: Randomized prospective study: radical prostatectomy alone vs. radical prostatectomy preceded by androgen block-age in cT2b prostate cancer (abstract 976). J Urol 155: 555A, 1996.
-
(1996)
J Urol
, vol.155
-
-
Soloway, M.S.1
Sharifi, R.2
Wajsman, Z.3
McLeod, D.4
Wood, D.5
Puras-Baez, A.6
-
4
-
-
0006910144
-
Update on neoadjuvant androgen deprivation therapy (ADT) and radical prostatectomy in localized prostate cancer
-
abstract 1426
-
Fair WR, Cookson MS, Stroumbakis N, Wang Y, Aprikian AG, Cohen D, Soloway SM, Russo P, Dalbagni G, Sheinfeld J, et al: Update on neoadjuvant androgen deprivation therapy (ADT) and radical prostatectomy in localized prostate cancer (abstract 1426). J Urol 155: 667A, 1996.
-
(1996)
J Urol
, vol.155
-
-
Fair, W.R.1
Cookson, M.S.2
Stroumbakis, N.3
Wang, Y.4
Aprikian, A.G.5
Cohen, D.6
Soloway, S.M.7
Russo, P.8
Dalbagni, G.9
Sheinfeld, J.10
-
5
-
-
0042570883
-
Neoadjuvant cyproterone acetate therapy prior to radical prostatectomy reduces tumour burden and margin positivity without altering 6 and 12 month post-treatment PSA: Results of a randomized trial
-
abstract 356
-
Klotz LH, Goldenberg LS, Bullock MJ, Srigley JR, Lapalante S, and the Canadian Uro-Oncology Group: Neoadjuvant cyproterone acetate therapy prior to radical prostatectomy reduces tumour burden and margin positivity without altering 6 and 12 month post-treatment PSA: results of a randomized trial (abstract 356). J Urol 155: 399A, 1996.
-
(1996)
J Urol
, vol.155
-
-
Klotz, L.H.1
Goldenberg, L.S.2
Bullock, M.J.3
Srigley, J.R.4
Lapalante, S.5
|